What one share of Cumberland Pharmaceuticals holds
Cumberland Pharmaceuticals Inc. ("Cumberland," the "Company," or as used in the context of "we," "us" or "our"), is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceuticals.
Cumberland Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.68 |
|---|---|
| Profit | −$0.73 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.05 |
| Cash and investments | $0.26 |
| Book value | $1.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $2.39 | $0.17 | $0.03 | −$0.01 | — | $5.09 |
| 2010 | $2.18 | $0.12 | $0.03 | −$0.01 | — | $3.82 |
| 2011 | $2.49 | $0.28 | $0.01 | $0.41 | — | $4.14 |
| 2012 | $2.47 | $0.30 | $0.02 | $0.34 | — | $4.53 |
| 2013 | $1.75 | −$0.11 | $0.01 | $0.04 | — | $4.42 |
| 2014 | $2.06 | $0.14 | $0.01 | $0.36 | — | $4.72 |
| 2015 | $1.96 | $0.04 | $0.01 | $0.34 | — | $4.69 |
| 2016 | $2.03 | −$0.06 | $0.01 | $0.03 | — | $4.56 |
| 2017 | $2.59 | −$0.50 | $0.02 | −$0.05 | — | $3.99 |
| 2018 | $1.88 | −$0.45 | $0.03 | $0.17 | — | $3.61 |
| 2019 | $2.23 | −$0.23 | $0.02 | $0.18 | — | $3.35 |
| 2020 | $2.47 | −$0.22 | $0.01 | $0.35 | — | $3.14 |
| 2021 | $2.41 | −$0.24 | $0.01 | $0.42 | — | $2.90 |
| 2022 | $2.88 | −$0.38 | $0.01 | $0.57 | — | $2.52 |
| 2023 | $2.77 | −$0.44 | $0.02 | $0.41 | — | $2.10 |
| 2024 | $2.69 | −$0.46 | $0.00 | −$0.05 | — | $1.64 |
| 2025 | $3.00 | −$0.19 | $0.01 | $0.33 | — | $1.66 |
Common questions about Cumberland Pharmaceuticals
How much does one share of Cumberland Pharmaceuticals earn?
Over the last 12 months, Cumberland Pharmaceuticals lost $0.73 for each share on $2.68 of sales.
Does Cumberland Pharmaceuticals pay a dividend?
Cumberland Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cumberland Pharmaceuticals’s book value per share?
Cumberland Pharmaceuticals’s book value is $1.16 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Cumberland Pharmaceuticals have?
Each share of Cumberland Pharmaceuticals has $0.26 of cash and investments, as of June 30, 2026.
What is Cumberland Pharmaceuticals’s free cash flow per share?
$0.05 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Cumberland Pharmaceuticals bought back shares?
Cumberland Pharmaceuticals’s share count fell about 19% from 2009 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.